ROLE OF FABP1 AS A DIAGNOSTIC BIOMARKER FOR NON-ALCOHOLIC FATTY PANCREATIC DISEASE

Chemerin As A Non-Invasive Serum Marker for Non-Alcoholic Fatty Liver Disease

Prognostic value of liver fatty acid-binding protein (FABPs) for impairment of renal function in type2 diabetic (T2D) patients

Non-invasive Methods in Diagnosis of Nonalcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease

Role of Activin A as A Novel Marker for Diagnosis and Evaluation of Nonalchoholic Fatty Liver Disease

Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.

The Expression Level of Long Non-Coding RNA PVT1 as a Diagnostic Marker for Advanced Stages in Patients with Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease (NAFLD)

Role of Fatty Acid Binding Protein 1 in Non- Alcoholic Fatty Pancreatic Disease with and without Diabetes Mellitus